OptiBiotix Health PLC (OPTI)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

5.70p

Buy

6.20p

arrow-up0.00p (+0.00%)

Prices updated at 19 Jun 2026, 16:22 BST
| Prices minimum 15 mins delay
|
Prices in GBX

OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health ...
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Richard Colin Neil Davidson CBE
CEO
Mr. Stephen Patrick O'Hara
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
9
Head office
Innovation Centre, Innovation Way
York
United Kingdom
YO10 5DG
mobile
+44 7721978218
letter
info@optibiotix.com

Key personnel

Salary
Mr. Richard Colin Neil Davidson CBE
Non-Executive Director, Chairman
-
Mr. Michael Sean Christie
Non-Executive Director
-
Dr. Sofia Kolyda
Executive Director, Research and Development Director
-
Mr. David Jonathan Blain
Executive Director, Finance Director and Company Secretary
-
Mr. Stephen Patrick O'Hara
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
No data

Director dealings

Action
28 May 2026Purchase
01 Oct 2025Purchase
23 Sep 2025Purchase
23 Sep 2025Purchase
22 Sep 2025Purchase
22 Sep 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.